IBB241227P130000
- 0.05
- -0.09-64.29%
iShares Biotechnology ETF Newsroom
Top Dividend Picks for 2025 According to Seeking Alpha's Quant Metrics
10 Health Care Stocks With Whale Alerts In Today's Session
Sector Update: Health Care Stocks Steady Premarket Thursday
Assembly Bio Spikes After Early-stage Data for Gilead-partnered Hep B Therapy
Exchange-Traded Funds, US Equities Higher in Tuesday's Shortened Trading
Sector Update: Health Care Stocks Mixed Premarket Tuesday
How Is The Market Feeling About Alnylam Pharmaceuticals?
Mizuho CEO Sees Global Boom in M&A After Trump Takes Office
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Spotlight on Amgen: Analyzing the Surge in Options Activity
Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst
Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday
2024's Top and Bottom Nasdaq-100 Performers Includes NVDA, APP, INTC, MRNA, and More
Waters Analyst Ratings
Sector Update: Health Care Stocks Fall Premarket Monday
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
JP Morgan Maintains Overweight on Vertex Pharmaceuticals, Lowers Price Target to $500
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday as Investors Assess Fed's Interest Rate Outlook
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More